Support from pharmaceutical companies
Please refer to our policy to understand how we work with healthcare and pharmaceutical companies. Acceptance of donations does not mean that we endorse their products and under no circumstances can these companies influence our strategic direction, activities or the content of the information and support we provide to people affected by lymphoma.
Funding received in 2026*
- Abbvie, £15,000
- Contributed towards our Patient Empowerment Toolkit
- Bristol Myers Squibb, £12,500
- Contributed towards our mission and objectives
- Sponsorship of our National Conference
- BeOne Medicines, £20,000
- Contributed towards our Lymphoma TrialsLink
- Sponsorship of our Lymphoma Management Course for HCPs
- Incyte, £5,000
- Sponsorship of our National Conference
- Kyowa Kirin, £20,000
- Contributed towards our Publications, Preparing for Treatment and Peer Support Services
- Sponsorship of our National Conference
- Pfizer, £5,000
- Sponsorship of our National Conference
- Takeda, £10,000
- Contributed towards our Publications and Preparing for Treatment service
*Updated May, 2026
Funding received in 2025*
- AbbVie, £15,000
- Contributed towards our Information Provision, Helpline and Live Your Life workshops
- AstraZeneca, £15,000
- Contributed towards our Information Provision and Helpline
- BeOne Medicines, £20,000
- Contributed towards our Lymphoma TrialsLink
- Sponsorship of our Lymphoma Management course for HCPs
- Bristol Myers Squibb, £10,000
- Contributed towards our mission and objectives
- Gilead Sciences Ltd, £14,000
- Contributed towards our Preparing for Treatment service and Lymphoma Essentials
- Sponsorship of our Lymphoma Information Days
- Johnson & Johnson, £5,000
- Sponsorship of our Lymphoma Management course for HCPs
- Kyowa Kirin, £19,000
- Contributed towards our Preparing for Treatment service, Lymphoma Essentials, and Information Provision
- Sponsorship of our Lymphoma Information Days
- Pfizer, £4,000
- Sponsorship of our Lymphoma Information Days
- Recordati, £5,000
- Contributed towards our Cutaneous Information Provision
- Roche, £25,000
- Contributed towards our Information Provision and Peer Support Services
- Sponsorship of our Lymphoma Management course for HCPs
- Serb, £10,000
- Contributed towards our Lymphoma Essentials provision
- Sobi, £7,500
- Contributed towards our Preparing for Treatment service
- Takeda UK Ltd £34,000
- Contributed towards our Information provision
- Contributed towards our Preparing for Treatment service and Lymphoma Essentials
- Sponsorship of our Lymphoma Information Days
*Updated November, 2025
Funding received in 2024*
- Incyte Biosciences £10,000
- Contributed towards our Information provision.
- Takeda UK Ltd £20,000
- Contributed towards our Helpline, Live your Life workshops and sponsorship of Lymphoma Management course for HCPs.
- Gilead Sciences Ltd £40,000
- Contributed towards our Peer Support Services and our Publications
- Roche £20,000
- Contributed towards our Helpline, Information Provision and Preparing for Treatment project.
- AbbVie Ltd £25,000
- Contributed towards our Preparing for Treatment project, Helpline and Information Provision.
- Kyowa Kirin £12,520
- Contributed towards our Preparing for Treatment project, Information Provision, Helpline and Workshop participation.
- Sobi £5,000
- Sponsorship of Lymphoma Management course for HCPs.
- Bristol Myers Squibb £8,000
- Contribution towards provision of support groups.
- BeiGene £20,561.34
- Contribution towards our Lymphoma Essentials and Preparing for Treatment provision and sponsorship of Lymphoma Management course for HCPs.
- Payment for patient volunteer expenses to attend BeiGene event.
- Serb Pharmaceuticals £5,000
- Contribution towards our Lymphoma Management course for HCPs.
- Novartis £10,000
- Contribution towards website accessibility project.
- Therakos £19,340
- Contribution towards our support groups
- AstraZeneca £15,000
- Contribution towards our Preparing for Treatment provision
- Janssen £5,000
- Contribution towards our Lymphoma Essentials provision
*Updated 06 Feb 2025
Funding Received in 2023*
- Roche £15,000
- Contributed towards our helpline, Information Provisions and Live your Life campaign.
- Gilead £50,698
- Contributed towards our Peer Support Network and our new Preparing for Treatment project.
- Takeda £15,000
- Contributed towards our National Conference and publications including Lymphoma Matters magazine.
- Sobi £15,000
- Contributed towards our Helpline, Information Provisions and Live your Life campaign.
- Kyowa Kirin £10,000
- Contributed towards our Healthcare Professional project lead.
- BMS Celegne £10,000
- Contributed towards our Helpline and Information Provisions.
- AbbVie £10,000
- Contributed towards our Helpline and publications including Lymphoma Matters magazine.
- BeiGene £24,000
- Contributed towards our Lymphoma Management Course.
- Incyte Biosciences £11,583
- Contributed towards our publications including Lymphoma Matters.
- Recordati Rare Diseases £5,000
- Contributed towards our new Healthcare professional project.
- Serb Pharmaceuticals £10,000
- Contributed towards our Helpline and Live your Life self-management course.
*Updated February 2024
Funding Received in 2022*
- Incyte Biosciences UK Ltd £22,750
- Contributed towards our publications, Lymphoma Matters magazine, education programmes for people affected by lymphoma, health inequalities project, Lymphoma Management course.
- Workshop participation.
- Kyowa Kirin £12,150
- Contributed towards TrialsLink, webpages, health inequalities project, Lymphoma Management course and our information and support services.
- Takeda £16,000
- Contributed towards our Lymphoma Matters magazine, health inequalities project, publications and Lymphoma Management course.
- Roche £26,000
- Contributed towards our digital events, TrialsLink and Lymphoma Management course.
- AbbVie £10,000
- Contributed towards our education programmes for people affected by lymphoma.
- Gilead £45,870
- Contributed towards health inequalities project, publications and Lymphoma Management course.
- Eli Lilly £11,000
- Contributed towards our publications, Lymphoma Matters magazine and Lymphoma Management course.
- Janssen £12,500
- Contributed towards our publications and education programmes for people affected by lymphoma.
- BMS £11,000
- Contributed towards our publications, Lymphoma Matters magazine and Lymphoma Management course.
- AstraZeneca £11,000
- Contributed towards our publications, website mobile optimisation and Lymphoma Management course.
- Novartis £1,000
- Contributed towards Lymphoma Management course.
- Pfizer £300
- Workshop participation.
*Updated March 2023